The LYNX technology originated in the Traverso and Langer Laboratories at MIT, with which Lyndra has an exclusive technology license.

Lyndra Therapeutics and Thermo Fisher Scientific have entered a strategic partnership to develop Lyndra's long-acting oral ...

The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.